Trade Mark Journal No.2026/009 27 February 2026
WO0000001901831 (5)
Office of origin: United States of America
Date of International Registration:14 January 2026
Date of designation in the UK:
14 January 2026

International priority date claimed: 15 July 2025
(United States of America)
(99284130)
- Class 5
- Pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for use in oncology.
Immunome, Inc.
Representative: Joyce Liou Morrison & Foerster LLP, 425 Market Street, San Francisco CA 94105, UNITED STATES OF AMERICA